D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 133 SEK -3.62% Market Closed
Market Cap: 2.2B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Devyser Diagnostics AB
Free Cash Flow Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Free Cash Flow
-kr101.7m
CAGR 3-Years
-232%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Free Cash Flow
kr377.4m
CAGR 3-Years
23%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Free Cash Flow
-kr3m
CAGR 3-Years
68%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Free Cash Flow
kr655m
CAGR 3-Years
8%
CAGR 5-Years
14%
CAGR 10-Years
16%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Free Cash Flow
kr3.3B
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
38%
BioArctic AB
STO:BIOA B
Free Cash Flow
kr302.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Free Cash Flow?
Free Cash Flow
-101.7m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Free Cash Flow amounts to -101.7m SEK.

What is Devyser Diagnostics AB's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-232%

Over the last year, the Free Cash Flow growth was -53%. The average annual Free Cash Flow growth rates for Devyser Diagnostics AB have been -232% over the past three years .

Back to Top